Author

Thomas Boyer

Centre National de la Recherche ScientifiqueORCID 0000-0001-8133-5491Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Adeline BarthélémyiD· 1 shared Adriana PleșaiD· 1 shared Antonino BongiovanniiD· 1 shared Céline BerthoniD· 1 shared Christophe RoumieriD· 1 shared Claude PreudhommeiD· 1 shared Djohana Laurent· 1 shared Fanny GonzalesiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adeline BarthélémyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintSep 20, 2023

Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia

Fanny Gonzales, Pauline Peyrouze, Thomas Boyer…·Meyling Hua-Chen Cheok

This study identifies CD81 as a marker of aggressive AML and shows anti-CD81 therapy improves survival in AML models.

DOI 10.1101/2023.09.20.558656

mousebulk RNA-seq

𝕏 PostBluesky